TI
AEGR

Turner Investments’s Aegerion Pharmaceuticals AEGR Stock Holding History

Turner Investments’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-37,330
Closed -$977K – 450
2015
Q1 		$977K Sell
37,330
-47,640
-56% -$1.21M 0.18% 155
2014
Q4 		$1.78M Sell
84,970
-33,080
-28% -$834K 0.21% 168
2014
Q3 		$3.94M Sell
118,050
-740
-0.6% -$23K 0.24% 138
2014
Q2 		$3.81M Buy
118,790
+90,490
+320% +$3.37M 0.17% 170
2014
Q1 		$1.31M Sell
28,300
-355,009
-93% -$20.8M 0.03% 420
2013
Q4 		$27.2M Buy
383,309
+128,299
+50% +$9.81M 0.49% 54
2013
Q3 		$21.9M Sell
255,010
-12,490
-5% -$1.06M 0.36% 85
2013
Q2 		$16.9M Buy
+267,500
New +$14.2M 0.23% 166

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Turner Investments's AEGR Position: Q2 2015 in Review

Turner Investments sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2015, closing a stake of 37,330 shares — an estimated $977K sold.

Turner Investments first reported a position in AEGR in Q2 2013 and held it in 8 quarters. The position peaked at $27.2M in Q4 2013. 97 funds tracked by Wall St. Rank hold AEGR as of Q2 2015.

  • Turner Investments reported no remaining Aegerion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Turner Investments sold 37,330 Aegerion Pharmaceuticals shares in Q2 2015, an estimated $977K.
  • Turner Investments first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • Turner Investments's Aegerion Pharmaceuticals position peaked at $27.2M in Q4 2013.
  • 97 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2015.

Based on Turner Investments's 13F filing for Q2 2015, filed 12 Aug 2015.